Tenaya Therapeutics, Inc. (TNYA)
0.8573
-0.08
(-8.31%)
USD |
NASDAQ |
May 15, 16:00
0.84
-0.02
(-2.02%)
After-Hours: 20:00
Tenaya Therapeutics Enterprise Value : 115.26M for May 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Marker Therapeutics, Inc. | 8.037M |
| Alnylam Pharmaceuticals, Inc. | 38.28B |
| Krystal Biotech, Inc. | 8.215B |
| Vericel Corp. | 1.638B |
| Anavex Life Sciences Corp. | 137.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.27M |
| Revenue (Quarterly) | 0.225M |
| Total Expenses (Quarterly) | 19.50M |
| EPS Diluted (Quarterly) | -0.0889 |
| Gross Profit Margin (Quarterly) | -683.6% |
| Profit Margin (Quarterly) | -8.57K% |
| Earnings Yield | -54.96% |
| Normalized Earnings Yield | -54.97 |